Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (T40)

Browse all the diagnosis codes used for poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (t40). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

Alfentanil - A short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.

Alphaprodine - An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1067)

Buprenorphine - A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Buprenorphine, Naloxone Drug Combination - A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.

Butorphanol - A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.

Cannabinoid Hyperemesis Syndrome - Recurrent vomiting accompanied by nausea, abdominal pain and sometimes compulsive hot bathing behavior in chronic CANNABIS abuse.

Cannabinol - A physiologically inactive constituent of Cannabis sativa L.

Cannabis - The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.

Cocaine - An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

Cocaine Smoking - SMOKING of COCAINE.

Cocaine-Related Disorders - Disorders related or resulting from use of cocaine.

Codeine - An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.

Crack Cocaine - The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term crack was derived from the crackling sound made upon igniting of this form of cocaine for smoking.

Dextromoramide - An opioid analgesic structurally related to METHADONE and used in the treatment of severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1070)

Dextropropoxyphene - A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect.

Dextrorphan - Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.

Dihydromorphine - A semisynthetic analgesic used in the study of narcotic receptors.

Dronabinol - A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.

Ethylmorphine - A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function.

Ethylmorphine-N-Demethylase - A drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde.

Etorphine - A narcotic analgesic morphinan used as a sedative in veterinary practice.

Glucuronosyltransferase - A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.

Heroin - A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)

Heroin Dependence - Strong dependence or addiction, both physiological and emotional, upon HEROIN.

Hydrocodone - Narcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant.

Hydromorphone - An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.

Levopropoxyphene - A propionate derivative that is used to suppress coughing.

Levorphanol - A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.

Lysergic Acid Diethylamide - Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.

Marijuana Abuse - Use of marijuana associated with abnormal psychological, social, and or occupational functioning.

Marijuana Smoking - Inhaling and exhaling SMOKE from CANNABIS.

Medical Marijuana - Product of the CANNABIS plant, CANNABINOIDS, or synthetic derivatives thereof, used in the treatment of a wide range of clinical symptoms.

Meperidine - A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.

Mescaline - Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.

Methadone - A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Morphine - The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Morphine Dependence - Strong dependence, both physiological and emotional, upon morphine.

Morphine Derivatives - Analogs or derivatives of morphine.

Nalbuphine - A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS and an antagonist or partial agonist at MU RECEPTORS.

Oxycodone - A semisynthetic derivative of CODEINE.

Oxymorphone - An opioid analgesic with actions and uses similar to those of MORPHINE, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092)

Pentazocine - The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)

Phenazocine - An opioid analgesic with actions and uses similar to MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1095)

Phencyclidine - A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.

Phencyclidine Abuse - The misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning.

Phenoperidine - A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.

Promedol - A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta (isopromedol) and the gamma (trimeperidine) are active.

Psilocybin - The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN.

Receptors, Opioid, mu - A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.

Receptors, Phencyclidine - Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs.

Sufentanil - An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.

Thebaine - A drug that is derived from opium, which contains from 0.3-1.5% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance (opiate) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 (1985). (From Merck Index, 11th ed)

Tilidine - An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1097)

Tramadol - A narcotic analgesic proposed for severe pain. It may be habituating.

Instructional Notations

Type 2 Excludes

A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

  • drug dependence and related mental and behavioral disorders due to psychoactive substance use F10 F19

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T40

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)

        • Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (T40)

        • T40 Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]
        • T40.0 Poisoning by, adverse effect of and underdosing of opium
        • T40.0X Poisoning by, adverse effect of and underdosing of opium
        • T40.0X1 Poisoning by opium, accidental (unintentional)
        • T40.0X1A Poisoning by opium, accidental (unintentional), initial encounter
        • T40.0X1D Poisoning by opium, accidental (unintentional), subsequent encounter
        • T40.0X1S Poisoning by opium, accidental (unintentional), sequela
        • T40.0X2 Poisoning by opium, intentional self-harm
        • T40.0X2A Poisoning by opium, intentional self-harm, initial encounter
        • T40.0X2D Poisoning by opium, intentional self-harm, subsequent encounter
        • T40.0X2S Poisoning by opium, intentional self-harm, sequela
        • T40.0X3 Poisoning by opium, assault
        • T40.0X3A Poisoning by opium, assault, initial encounter
        • T40.0X3D Poisoning by opium, assault, subsequent encounter
        • T40.0X3S Poisoning by opium, assault, sequela
        • T40.0X4 Poisoning by opium, undetermined
        • T40.0X4A Poisoning by opium, undetermined, initial encounter
        • T40.0X4D Poisoning by opium, undetermined, subsequent encounter
        • T40.0X4S Poisoning by opium, undetermined, sequela
        • T40.0X5 Adverse effect of opium
        • T40.0X5A Adverse effect of opium, initial encounter
        • T40.0X5D Adverse effect of opium, subsequent encounter
        • T40.0X5S Adverse effect of opium, sequela
        • T40.0X6 Underdosing of opium
        • T40.0X6A Underdosing of opium, initial encounter
        • T40.0X6D Underdosing of opium, subsequent encounter
        • T40.0X6S Underdosing of opium, sequela
        • T40.1 Poisoning by and adverse effect of heroin
        • T40.1X Poisoning by and adverse effect of heroin
        • T40.1X1 Poisoning by heroin, accidental (unintentional)
        • T40.1X1A Poisoning by heroin, accidental (unintentional), initial encounter
        • T40.1X1D Poisoning by heroin, accidental (unintentional), subsequent encounter
        • T40.1X1S Poisoning by heroin, accidental (unintentional), sequela
        • T40.1X2 Poisoning by heroin, intentional self-harm
        • T40.1X2A Poisoning by heroin, intentional self-harm, initial encounter
        • T40.1X2D Poisoning by heroin, intentional self-harm, subsequent encounter
        • T40.1X2S Poisoning by heroin, intentional self-harm, sequela
        • T40.1X3 Poisoning by heroin, assault
        • T40.1X3A Poisoning by heroin, assault, initial encounter
        • T40.1X3D Poisoning by heroin, assault, subsequent encounter
        • T40.1X3S Poisoning by heroin, assault, sequela
        • T40.1X4 Poisoning by heroin, undetermined
        • T40.1X4A Poisoning by heroin, undetermined, initial encounter
        • T40.1X4D Poisoning by heroin, undetermined, subsequent encounter
        • T40.1X4S Poisoning by heroin, undetermined, sequela
        • T40.2 Poisoning by, adverse effect of and underdosing of other opioids
        • T40.2X Poisoning by, adverse effect of and underdosing of other opioids
        • T40.2X1 Poisoning by other opioids, accidental (unintentional)
        • T40.2X1A Poisoning by other opioids, accidental (unintentional), initial encounter
        • T40.2X1D Poisoning by other opioids, accidental (unintentional), subsequent encounter
        • T40.2X1S Poisoning by other opioids, accidental (unintentional), sequela
        • T40.2X2 Poisoning by other opioids, intentional self-harm
        • T40.2X2A Poisoning by other opioids, intentional self-harm, initial encounter
        • T40.2X2D Poisoning by other opioids, intentional self-harm, subsequent encounter
        • T40.2X2S Poisoning by other opioids, intentional self-harm, sequela
        • T40.2X3 Poisoning by other opioids, assault
        • T40.2X3A Poisoning by other opioids, assault, initial encounter
        • T40.2X3D Poisoning by other opioids, assault, subsequent encounter
        • T40.2X3S Poisoning by other opioids, assault, sequela
        • T40.2X4 Poisoning by other opioids, undetermined
        • T40.2X4A Poisoning by other opioids, undetermined, initial encounter
        • T40.2X4D Poisoning by other opioids, undetermined, subsequent encounter
        • T40.2X4S Poisoning by other opioids, undetermined, sequela
        • T40.2X5 Adverse effect of other opioids
        • T40.2X5A Adverse effect of other opioids, initial encounter
        • T40.2X5D Adverse effect of other opioids, subsequent encounter
        • T40.2X5S Adverse effect of other opioids, sequela
        • T40.2X6 Underdosing of other opioids
        • T40.2X6A Underdosing of other opioids, initial encounter
        • T40.2X6D Underdosing of other opioids, subsequent encounter
        • T40.2X6S Underdosing of other opioids, sequela
        • T40.3 Poisoning by, adverse effect of and underdosing of methadone
        • T40.3X Poisoning by, adverse effect of and underdosing of methadone
        • T40.3X1 Poisoning by methadone, accidental (unintentional)
        • T40.3X1A Poisoning by methadone, accidental (unintentional), initial encounter
        • T40.3X1D Poisoning by methadone, accidental (unintentional), subsequent encounter
        • T40.3X1S Poisoning by methadone, accidental (unintentional), sequela
        • T40.3X2 Poisoning by methadone, intentional self-harm
        • T40.3X2A Poisoning by methadone, intentional self-harm, initial encounter
        • T40.3X2D Poisoning by methadone, intentional self-harm, subsequent encounter
        • T40.3X2S Poisoning by methadone, intentional self-harm, sequela
        • T40.3X3 Poisoning by methadone, assault
        • T40.3X3A Poisoning by methadone, assault, initial encounter
        • T40.3X3D Poisoning by methadone, assault, subsequent encounter
        • T40.3X3S Poisoning by methadone, assault, sequela
        • T40.3X4 Poisoning by methadone, undetermined
        • T40.3X4A Poisoning by methadone, undetermined, initial encounter
        • T40.3X4D Poisoning by methadone, undetermined, subsequent encounter
        • T40.3X4S Poisoning by methadone, undetermined, sequela
        • T40.3X5 Adverse effect of methadone
        • T40.3X5A Adverse effect of methadone, initial encounter
        • T40.3X5D Adverse effect of methadone, subsequent encounter
        • T40.3X5S Adverse effect of methadone, sequela
        • T40.3X6 Underdosing of methadone
        • T40.3X6A Underdosing of methadone, initial encounter
        • T40.3X6D Underdosing of methadone, subsequent encounter
        • T40.3X6S Underdosing of methadone, sequela
        • T40.4 Poisoning by, adverse effect of and underdosing of other synthetic narcotics
        • T40.41 Poisoning by, adverse effect of and underdosing of fentanyl or fentanyl analogs
        • T40.411 Poisoning by fentanyl or fentanyl analogs, accidental (unintentional)
        • T40.411A Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter
        • T40.411D Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), subsequent encounter
        • T40.411S Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), sequela
        • T40.412 Poisoning by fentanyl or fentanyl analogs, intentional self-harm
        • T40.412A Poisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter
        • T40.412D Poisoning by fentanyl or fentanyl analogs, intentional self-harm, subsequent encounter
        • T40.412S Poisoning by fentanyl or fentanyl analogs, intentional self-harm, sequela
        • T40.413 Poisoning by fentanyl or fentanyl analogs, assault
        • T40.413A Poisoning by fentanyl or fentanyl analogs, assault, initial encounter
        • T40.413D Poisoning by fentanyl or fentanyl analogs, assault, subsequent encounter
        • T40.413S Poisoning by fentanyl or fentanyl analogs, assault, sequela
        • T40.414 Poisoning by fentanyl or fentanyl analogs, undetermined
        • T40.414A Poisoning by fentanyl or fentanyl analogs, undetermined, initial encounter
        • T40.414D Poisoning by fentanyl or fentanyl analogs, undetermined, subsequent encounter
        • T40.414S Poisoning by fentanyl or fentanyl analogs, undetermined, sequela
        • T40.415 Adverse effect of fentanyl or fentanyl analogs
        • T40.415A Adverse effect of fentanyl or fentanyl analogs, initial encounter
        • T40.415D Adverse effect of fentanyl or fentanyl analogs, subsequent encounter
        • T40.415S Adverse effect of fentanyl or fentanyl analogs, sequela
        • T40.416 Underdosing of fentanyl or fentanyl analogs
        • T40.416A Underdosing of fentanyl or fentanyl analogs, initial encounter
        • T40.416D Underdosing of fentanyl or fentanyl analogs, subsequent encounter
        • T40.416S Underdosing of fentanyl or fentanyl analogs, sequela
        • T40.42 Poisoning by, adverse effect of and underdosing of tramadol
        • T40.421 Poisoning by tramadol, accidental (unintentional)
        • T40.421A Poisoning by tramadol, accidental (unintentional), initial encounter
        • T40.421D Poisoning by tramadol, accidental (unintentional), subsequent encounter
        • T40.421S Poisoning by tramadol, accidental (unintentional), sequela
        • T40.422 Poisoning by tramadol, intentional self-harm
        • T40.422A Poisoning by tramadol, intentional self-harm, initial encounter
        • T40.422D Poisoning by tramadol, intentional self-harm, subsequent encounter
        • T40.422S Poisoning by tramadol, intentional self-harm, sequela
        • T40.423 Poisoning by tramadol, assault
        • T40.423A Poisoning by tramadol, assault, initial encounter
        • T40.423D Poisoning by tramadol, assault, subsequent encounter
        • T40.423S Poisoning by tramadol, assault, sequela
        • T40.424 Poisoning by tramadol, undetermined
        • T40.424A Poisoning by tramadol, undetermined, initial encounter
        • T40.424D Poisoning by tramadol, undetermined, subsequent encounter
        • T40.424S Poisoning by tramadol, undetermined, sequela
        • T40.425 Adverse effect of tramadol
        • T40.425A Adverse effect of tramadol, initial encounter
        • T40.425D Adverse effect of tramadol, subsequent encounter
        • T40.425S Adverse effect of tramadol, sequela
        • T40.426 Underdosing of tramadol
        • T40.426A Underdosing of tramadol, initial encounter
        • T40.426D Underdosing of tramadol, subsequent encounter
        • T40.426S Underdosing of tramadol, sequela
        • T40.49 Poisoning by, adverse effect of and underdosing of other synthetic narcotics
        • T40.491 Poisoning by other synthetic narcotics, accidental (unintentional)
        • T40.491A Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
        • T40.491D Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter
        • T40.491S Poisoning by other synthetic narcotics, accidental (unintentional), sequela
        • T40.492 Poisoning by other synthetic narcotics, intentional self-harm
        • T40.492A Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
        • T40.492D Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter
        • T40.492S Poisoning by other synthetic narcotics, intentional self-harm, sequela
        • T40.493 Poisoning by other synthetic narcotics, assault
        • T40.493A Poisoning by other synthetic narcotics, assault, initial encounter
        • T40.493D Poisoning by other synthetic narcotics, assault, subsequent encounter
        • T40.493S Poisoning by other synthetic narcotics, assault, sequela
        • T40.494 Poisoning by other synthetic narcotics, undetermined
        • T40.494A Poisoning by other synthetic narcotics, undetermined, initial encounter
        • T40.494D Poisoning by other synthetic narcotics, undetermined, subsequent encounter
        • T40.494S Poisoning by other synthetic narcotics, undetermined, sequela
        • T40.495 Adverse effect of other synthetic narcotics
        • T40.495A Adverse effect of other synthetic narcotics, initial encounter
        • T40.495D Adverse effect of other synthetic narcotics, subsequent encounter
        • T40.495S Adverse effect of other synthetic narcotics, sequela
        • T40.496 Underdosing of other synthetic narcotics
        • T40.496A Underdosing of other synthetic narcotics, initial encounter
        • T40.496D Underdosing of other synthetic narcotics, subsequent encounter
        • T40.496S Underdosing of other synthetic narcotics, sequela
        • T40.5 Poisoning by, adverse effect of and underdosing of cocaine
        • T40.5X Poisoning by, adverse effect of and underdosing of cocaine
        • T40.5X1 Poisoning by cocaine, accidental (unintentional)
        • T40.5X1A Poisoning by cocaine, accidental (unintentional), initial encounter
        • T40.5X1D Poisoning by cocaine, accidental (unintentional), subsequent encounter
        • T40.5X1S Poisoning by cocaine, accidental (unintentional), sequela
        • T40.5X2 Poisoning by cocaine, intentional self-harm
        • T40.5X2A Poisoning by cocaine, intentional self-harm, initial encounter
        • T40.5X2D Poisoning by cocaine, intentional self-harm, subsequent encounter
        • T40.5X2S Poisoning by cocaine, intentional self-harm, sequela
        • T40.5X3 Poisoning by cocaine, assault
        • T40.5X3A Poisoning by cocaine, assault, initial encounter
        • T40.5X3D Poisoning by cocaine, assault, subsequent encounter
        • T40.5X3S Poisoning by cocaine, assault, sequela
        • T40.5X4 Poisoning by cocaine, undetermined
        • T40.5X4A Poisoning by cocaine, undetermined, initial encounter
        • T40.5X4D Poisoning by cocaine, undetermined, subsequent encounter
        • T40.5X4S Poisoning by cocaine, undetermined, sequela
        • T40.5X5 Adverse effect of cocaine
        • T40.5X5A Adverse effect of cocaine, initial encounter
        • T40.5X5D Adverse effect of cocaine, subsequent encounter
        • T40.5X5S Adverse effect of cocaine, sequela
        • T40.5X6 Underdosing of cocaine
        • T40.5X6A Underdosing of cocaine, initial encounter
        • T40.5X6D Underdosing of cocaine, subsequent encounter
        • T40.5X6S Underdosing of cocaine, sequela
        • T40.6 Poisoning by, adverse effect of and underdosing of other and unspecified narcotics
        • T40.60 Poisoning by, adverse effect of and underdosing of unspecified narcotics
        • T40.601 Poisoning by unspecified narcotics, accidental (unintentional)
        • T40.601A Poisoning by unspecified narcotics, accidental (unintentional), initial encounter
        • T40.601D Poisoning by unspecified narcotics, accidental (unintentional), subsequent encounter
        • T40.601S Poisoning by unspecified narcotics, accidental (unintentional), sequela
        • T40.602 Poisoning by unspecified narcotics, intentional self-harm
        • T40.602A Poisoning by unspecified narcotics, intentional self-harm, initial encounter
        • T40.602D Poisoning by unspecified narcotics, intentional self-harm, subsequent encounter
        • T40.602S Poisoning by unspecified narcotics, intentional self-harm, sequela
        • T40.603 Poisoning by unspecified narcotics, assault
        • T40.603A Poisoning by unspecified narcotics, assault, initial encounter
        • T40.603D Poisoning by unspecified narcotics, assault, subsequent encounter
        • T40.603S Poisoning by unspecified narcotics, assault, sequela
        • T40.604 Poisoning by unspecified narcotics, undetermined
        • T40.604A Poisoning by unspecified narcotics, undetermined, initial encounter
        • T40.604D Poisoning by unspecified narcotics, undetermined, subsequent encounter
        • T40.604S Poisoning by unspecified narcotics, undetermined, sequela
        • T40.605 Adverse effect of unspecified narcotics
        • T40.605A Adverse effect of unspecified narcotics, initial encounter
        • T40.605D Adverse effect of unspecified narcotics, subsequent encounter
        • T40.605S Adverse effect of unspecified narcotics, sequela
        • T40.606 Underdosing of unspecified narcotics
        • T40.606A Underdosing of unspecified narcotics, initial encounter
        • T40.606D Underdosing of unspecified narcotics, subsequent encounter
        • T40.606S Underdosing of unspecified narcotics, sequela
        • T40.69 Poisoning by, adverse effect of and underdosing of other narcotics
        • T40.691 Poisoning by other narcotics, accidental (unintentional)
        • T40.691A Poisoning by other narcotics, accidental (unintentional), initial encounter
        • T40.691D Poisoning by other narcotics, accidental (unintentional), subsequent encounter
        • T40.691S Poisoning by other narcotics, accidental (unintentional), sequela
        • T40.692 Poisoning by other narcotics, intentional self-harm
        • T40.692A Poisoning by other narcotics, intentional self-harm, initial encounter
        • T40.692D Poisoning by other narcotics, intentional self-harm, subsequent encounter
        • T40.692S Poisoning by other narcotics, intentional self-harm, sequela
        • T40.693 Poisoning by other narcotics, assault
        • T40.693A Poisoning by other narcotics, assault, initial encounter
        • T40.693D Poisoning by other narcotics, assault, subsequent encounter
        • T40.693S Poisoning by other narcotics, assault, sequela
        • T40.694 Poisoning by other narcotics, undetermined
        • T40.694A Poisoning by other narcotics, undetermined, initial encounter
        • T40.694D Poisoning by other narcotics, undetermined, subsequent encounter
        • T40.694S Poisoning by other narcotics, undetermined, sequela
        • T40.695 Adverse effect of other narcotics
        • T40.695A Adverse effect of other narcotics, initial encounter
        • T40.695D Adverse effect of other narcotics, subsequent encounter
        • T40.695S Adverse effect of other narcotics, sequela
        • T40.696 Underdosing of other narcotics
        • T40.696A Underdosing of other narcotics, initial encounter
        • T40.696D Underdosing of other narcotics, subsequent encounter
        • T40.696S Underdosing of other narcotics, sequela
        • T40.7 Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
        • T40.71 Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
        • T40.711 Poisoning by cannabis, accidental (unintentional)
        • T40.711A Poisoning by cannabis, accidental (unintentional), initial encounter
        • T40.711D Poisoning by cannabis, accidental (unintentional), subsequent encounter
        • T40.711S Poisoning by cannabis, accidental (unintentional), sequela
        • T40.712 Poisoning by cannabis, intentional self-harm
        • T40.712A Poisoning by cannabis, intentional self-harm, initial encounter
        • T40.712D Poisoning by cannabis, intentional self-harm, subsequent encounter
        • T40.712S Poisoning by cannabis, intentional self-harm, sequela
        • T40.713 Poisoning by cannabis, assault
        • T40.713A Poisoning by cannabis, assault, initial encounter
        • T40.713D Poisoning by cannabis, assault, subsequent encounter
        • T40.713S Poisoning by cannabis, assault, sequela
        • T40.714 Poisoning by cannabis, undetermined
        • T40.714A Poisoning by cannabis, undetermined, initial encounter
        • T40.714D Poisoning by cannabis, undetermined, subsequent encounter
        • T40.714S Poisoning by cannabis, undetermined, sequela
        • T40.715 Adverse effect of cannabis
        • T40.715A Adverse effect of cannabis, initial encounter
        • T40.715D Adverse effect of cannabis, subsequent encounter
        • T40.715S Adverse effect of cannabis, sequela
        • T40.716 Underdosing of cannabis
        • T40.716A Underdosing of cannabis, initial encounter
        • T40.716D Underdosing of cannabis, subsequent encounter
        • T40.716S Underdosing of cannabis, sequela
        • T40.72 Poisoning by, adverse effect of and underdosing of synthetic cannabinoids
        • T40.721 Poisoning by synthetic cannabinoids, accidental (unintentional)
        • T40.721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
        • T40.721D Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
        • T40.721S Poisoning by synthetic cannabinoids, accidental (unintentional), sequela
        • T40.722 Poisoning by synthetic cannabinoids, intentional self-harm
        • T40.722A Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
        • T40.722D Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
        • T40.722S Poisoning by synthetic cannabinoids, intentional self-harm, sequela
        • T40.723 Poisoning by synthetic cannabinoids, assault
        • T40.723A Poisoning by synthetic cannabinoids, assault, initial encounter
        • T40.723D Poisoning by synthetic cannabinoids, assault, subsequent encounter
        • T40.723S Poisoning by synthetic cannabinoids, assault, sequela
        • T40.724 Poisoning by synthetic cannabinoids, undetermined
        • T40.724A Poisoning by synthetic cannabinoids, undetermined, initial encounter
        • T40.724D Poisoning by synthetic cannabinoids, undetermined, subsequent encounter
        • T40.724S Poisoning by synthetic cannabinoids, undetermined, sequela
        • T40.725 Adverse effect of synthetic cannabinoids
        • T40.725A Adverse effect of synthetic cannabinoids, initial encounter
        • T40.725D Adverse effect of synthetic cannabinoids, subsequent encounter
        • T40.725S Adverse effect of synthetic cannabinoids, sequela
        • T40.726 Underdosing of synthetic cannabinoids
        • T40.726A Underdosing of synthetic cannabinoids, initial encounter
        • T40.726D Underdosing of synthetic cannabinoids, subsequent encounter
        • T40.726S Underdosing of synthetic cannabinoids, sequela
        • T40.8 Poisoning by and adverse effect of lysergide [LSD]
        • T40.8X Poisoning by and adverse effect of lysergide [LSD]
        • T40.8X1 Poisoning by lysergide [LSD], accidental (unintentional)
        • T40.8X1A Poisoning by lysergide [LSD], accidental (unintentional), initial encounter
        • T40.8X1D Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter
        • T40.8X1S Poisoning by lysergide [LSD], accidental (unintentional), sequela
        • T40.8X2 Poisoning by lysergide [LSD], intentional self-harm
        • T40.8X2A Poisoning by lysergide [LSD], intentional self-harm, initial encounter
        • T40.8X2D Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter
        • T40.8X2S Poisoning by lysergide [LSD], intentional self-harm, sequela
        • T40.8X3 Poisoning by lysergide [LSD], assault
        • T40.8X3A Poisoning by lysergide [LSD], assault, initial encounter
        • T40.8X3D Poisoning by lysergide [LSD], assault, subsequent encounter
        • T40.8X3S Poisoning by lysergide [LSD], assault, sequela
        • T40.8X4 Poisoning by lysergide [LSD], undetermined
        • T40.8X4A Poisoning by lysergide [LSD], undetermined, initial encounter
        • T40.8X4D Poisoning by lysergide [LSD], undetermined, subsequent encounter
        • T40.8X4S Poisoning by lysergide [LSD], undetermined, sequela
        • T40.9 Poisoning by, adverse effect of and underdosing of other and unspecified psychodysleptics [hallucinogens]
        • T40.90 Poisoning by, adverse effect of and underdosing of unspecified psychodysleptics [hallucinogens]
        • T40.901 Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional)
        • T40.901A Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
        • T40.901D Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
        • T40.901S Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), sequela
        • T40.902 Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm
        • T40.902A Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
        • T40.902D Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
        • T40.902S Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela
        • T40.903 Poisoning by unspecified psychodysleptics [hallucinogens], assault
        • T40.903A Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
        • T40.903D Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter
        • T40.903S Poisoning by unspecified psychodysleptics [hallucinogens], assault, sequela
        • T40.904 Poisoning by unspecified psychodysleptics [hallucinogens], undetermined
        • T40.904A Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
        • T40.904D Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter
        • T40.904S Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, sequela
        • T40.905 Adverse effect of unspecified psychodysleptics [hallucinogens]
        • T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
        • T40.905D Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
        • T40.905S Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
        • T40.906 Underdosing of unspecified psychodysleptics [hallucinogens]
        • T40.906A Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter
        • T40.906D Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
        • T40.906S Underdosing of unspecified psychodysleptics [hallucinogens], sequela
        • T40.99 Poisoning by, adverse effect of and underdosing of other psychodysleptics [hallucinogens]
        • T40.991 Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional)
        • T40.991A Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
        • T40.991D Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
        • T40.991S Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), sequela
        • T40.992 Poisoning by other psychodysleptics [hallucinogens], intentional self-harm
        • T40.992A Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
        • T40.992D Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
        • T40.992S Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, sequela
        • T40.993 Poisoning by other psychodysleptics [hallucinogens], assault
        • T40.993A Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter
        • T40.993D Poisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter
        • T40.993S Poisoning by other psychodysleptics [hallucinogens], assault, sequela
        • T40.994 Poisoning by other psychodysleptics [hallucinogens], undetermined
        • T40.994A Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
        • T40.994D Poisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter
        • T40.994S Poisoning by other psychodysleptics [hallucinogens], undetermined, sequela
        • T40.995 Adverse effect of other psychodysleptics [hallucinogens]
        • T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
        • T40.995D Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
        • T40.995S Adverse effect of other psychodysleptics [hallucinogens], sequela
        • T40.996 Underdosing of other psychodysleptics [hallucinogens]
        • T40.996A Underdosing of other psychodysleptics [hallucinogens], initial encounter
        • T40.996D Underdosing of other psychodysleptics [hallucinogens], subsequent encounter
        • T40.996S Underdosing of other psychodysleptics [hallucinogens], sequela